Selected research
Market Analysis & Forecast
Global Metagenomics Sequencing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Metagenomics Sequencing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Metagenomics Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Metagenomics Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Metagenomics Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Metagenomics Sequencing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Metagenomics Sequencing Services include Novogene, CD Genomics, BGI, MR DNA, Macrogen Europe, Norgen Biotek Corp., Psomagen, LC Sciences and IMGM, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Metagenomics Sequencing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Metagenomics Sequencing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Metagenomics Sequencing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Metagenomics Sequencing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Metagenomics Sequencing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Metagenomics Sequencing Services revenue, projected growth trends, production technology, application and end-user industry.
Metagenomics Sequencing Services Segment by Company
Novogene
CD Genomics
BGI
MR DNA
Macrogen Europe
Norgen Biotek Corp.
Psomagen
LC Sciences
IMGM
CosmosID
MicrobesNG
Synbio Technologies
NCIMB
Discovery Life Sciences
Nucleome
Creative Biolabs
Yaazh Xenomics
LGC Biosearch Technologies
AGTC Genomics
LabMal
GenomeScan
Metagenomics Sequencing Services Segment by Type
Amplicon Sequencing
Shotgun Sequencing
Others
Metagenomics Sequencing Services Segment by Application
Environmental Samples
Wastewater Analysis
Food Testing
Human Microbiome Sample
Others
Metagenomics Sequencing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metagenomics Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metagenomics Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metagenomics Sequencing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Metagenomics Sequencing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Metagenomics Sequencing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metagenomics Sequencing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Amplicon Sequencing
- Shotgun Sequencing
- Others
Applications
- Environmental Samples
- Wastewater Analysis
- Food Testing
- Human Microbiome Sample
- Others
Companies covered
- Novogene
- CD Genomics
- BGI
- MR DNA
- Macrogen Europe
- Norgen Biotek Corp.
- Psomagen
- LC Sciences
- IMGM
- CosmosID
- MicrobesNG
- Synbio Technologies
- NCIMB
- Discovery Life Sciences
- Nucleome
- Creative Biolabs
- Yaazh Xenomics
- LGC Biosearch Technologies
- AGTC Genomics
- LabMal
- GenomeScan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Metagenomics Sequencing Services Market by Type
- 1.2.1 Global Metagenomics Sequencing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Amplicon Sequencing
- 1.2.3 Shotgun Sequencing
- 1.2.4 Others
- 1.3 Metagenomics Sequencing Services Market by Application
- 1.3.1 Global Metagenomics Sequencing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Environmental Samples
- 1.3.3 Wastewater Analysis
- 1.3.4 Food Testing
- 1.3.5 Human Microbiome Sample
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Metagenomics Sequencing Services Market Dynamics
- 2.1 Metagenomics Sequencing Services Industry Trends
- 2.2 Metagenomics Sequencing Services Industry Drivers
- 2.3 Metagenomics Sequencing Services Industry Opportunities and Challenges
- 2.4 Metagenomics Sequencing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Metagenomics Sequencing Services Market Perspective (2021-2032)
- 3.2 Global Metagenomics Sequencing Services Growth Trends by Region
- 3.2.1 Global Metagenomics Sequencing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Metagenomics Sequencing Services Market Size by Region (2021-2026)
- 3.2.3 Global Metagenomics Sequencing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Metagenomics Sequencing Services Revenue by Players
- 4.1.1 Global Metagenomics Sequencing Services Revenue by Players (2021-2026)
- 4.1.2 Global Metagenomics Sequencing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Metagenomics Sequencing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Metagenomics Sequencing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Metagenomics Sequencing Services Key Players Headquarters & Area Served
- 4.4 Global Metagenomics Sequencing Services Players, Product Type & Application
- 4.5 Global Metagenomics Sequencing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Metagenomics Sequencing Services Market CR5 and HHI
- 4.6.3 2025 Metagenomics Sequencing Services Tier 1, Tier 2, and Tier 3
5 Metagenomics Sequencing Services Market Size by Type
- 5.1 Global Metagenomics Sequencing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 5.3 Global Metagenomics Sequencing Services Revenue Market Share by Type (2021-2032)
6 Metagenomics Sequencing Services Market Size by Application
- 6.1 Global Metagenomics Sequencing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 6.3 Global Metagenomics Sequencing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Novogene
- 7.1.1 Novogene Company Information
- 7.1.2 Novogene Business Overview
- 7.1.3 Novogene Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Novogene Metagenomics Sequencing Services Product Portfolio
- 7.1.5 Novogene Recent Developments
- 7.2 CD Genomics
- 7.2.1 CD Genomics Company Information
- 7.2.2 CD Genomics Business Overview
- 7.2.3 CD Genomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 CD Genomics Metagenomics Sequencing Services Product Portfolio
- 7.2.5 CD Genomics Recent Developments
- 7.3 BGI
- 7.3.1 BGI Company Information
- 7.3.2 BGI Business Overview
- 7.3.3 BGI Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 BGI Metagenomics Sequencing Services Product Portfolio
- 7.3.5 BGI Recent Developments
- 7.4 MR DNA
- 7.4.1 MR DNA Company Information
- 7.4.2 MR DNA Business Overview
- 7.4.3 MR DNA Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 MR DNA Metagenomics Sequencing Services Product Portfolio
- 7.4.5 MR DNA Recent Developments
- 7.5 Macrogen Europe
- 7.5.1 Macrogen Europe Company Information
- 7.5.2 Macrogen Europe Business Overview
- 7.5.3 Macrogen Europe Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Macrogen Europe Metagenomics Sequencing Services Product Portfolio
- 7.5.5 Macrogen Europe Recent Developments
- 7.6 Norgen Biotek Corp.
- 7.6.1 Norgen Biotek Corp. Company Information
- 7.6.2 Norgen Biotek Corp. Business Overview
- 7.6.3 Norgen Biotek Corp. Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Norgen Biotek Corp. Metagenomics Sequencing Services Product Portfolio
- 7.6.5 Norgen Biotek Corp. Recent Developments
- 7.7 Psomagen
- 7.7.1 Psomagen Company Information
- 7.7.2 Psomagen Business Overview
- 7.7.3 Psomagen Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Psomagen Metagenomics Sequencing Services Product Portfolio
- 7.7.5 Psomagen Recent Developments
- 7.8 LC Sciences
- 7.8.1 LC Sciences Company Information
- 7.8.2 LC Sciences Business Overview
- 7.8.3 LC Sciences Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 LC Sciences Metagenomics Sequencing Services Product Portfolio
- 7.8.5 LC Sciences Recent Developments
- 7.9 IMGM
- 7.9.1 IMGM Company Information
- 7.9.2 IMGM Business Overview
- 7.9.3 IMGM Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 IMGM Metagenomics Sequencing Services Product Portfolio
- 7.9.5 IMGM Recent Developments
- 7.10 CosmosID
- 7.10.1 CosmosID Company Information
- 7.10.2 CosmosID Business Overview
- 7.10.3 CosmosID Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 CosmosID Metagenomics Sequencing Services Product Portfolio
- 7.10.5 CosmosID Recent Developments
- 7.11 MicrobesNG
- 7.11.1 MicrobesNG Company Information
- 7.11.2 MicrobesNG Business Overview
- 7.11.3 MicrobesNG Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.11.4 MicrobesNG Metagenomics Sequencing Services Product Portfolio
- 7.11.5 MicrobesNG Recent Developments
- 7.12 Synbio Technologies
- 7.12.1 Synbio Technologies Company Information
- 7.12.2 Synbio Technologies Business Overview
- 7.12.3 Synbio Technologies Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.12.4 Synbio Technologies Metagenomics Sequencing Services Product Portfolio
- 7.12.5 Synbio Technologies Recent Developments
- 7.13 NCIMB
- 7.13.1 NCIMB Company Information
- 7.13.2 NCIMB Business Overview
- 7.13.3 NCIMB Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.13.4 NCIMB Metagenomics Sequencing Services Product Portfolio
- 7.13.5 NCIMB Recent Developments
- 7.14 Discovery Life Sciences
- 7.14.1 Discovery Life Sciences Company Information
- 7.14.2 Discovery Life Sciences Business Overview
- 7.14.3 Discovery Life Sciences Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.14.4 Discovery Life Sciences Metagenomics Sequencing Services Product Portfolio
- 7.14.5 Discovery Life Sciences Recent Developments
- 7.15 Nucleome
- 7.15.1 Nucleome Company Information
- 7.15.2 Nucleome Business Overview
- 7.15.3 Nucleome Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Nucleome Metagenomics Sequencing Services Product Portfolio
- 7.15.5 Nucleome Recent Developments
- 7.16 Creative Biolabs
- 7.16.1 Creative Biolabs Company Information
- 7.16.2 Creative Biolabs Business Overview
- 7.16.3 Creative Biolabs Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.16.4 Creative Biolabs Metagenomics Sequencing Services Product Portfolio
- 7.16.5 Creative Biolabs Recent Developments
- 7.17 Yaazh Xenomics
- 7.17.1 Yaazh Xenomics Company Information
- 7.17.2 Yaazh Xenomics Business Overview
- 7.17.3 Yaazh Xenomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.17.4 Yaazh Xenomics Metagenomics Sequencing Services Product Portfolio
- 7.17.5 Yaazh Xenomics Recent Developments
- 7.18 LGC Biosearch Technologies
- 7.18.1 LGC Biosearch Technologies Company Information
- 7.18.2 LGC Biosearch Technologies Business Overview
- 7.18.3 LGC Biosearch Technologies Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.18.4 LGC Biosearch Technologies Metagenomics Sequencing Services Product Portfolio
- 7.18.5 LGC Biosearch Technologies Recent Developments
- 7.19 AGTC Genomics
- 7.19.1 AGTC Genomics Company Information
- 7.19.2 AGTC Genomics Business Overview
- 7.19.3 AGTC Genomics Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.19.4 AGTC Genomics Metagenomics Sequencing Services Product Portfolio
- 7.19.5 AGTC Genomics Recent Developments
- 7.20 LabMal
- 7.20.1 LabMal Company Information
- 7.20.2 LabMal Business Overview
- 7.20.3 LabMal Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.20.4 LabMal Metagenomics Sequencing Services Product Portfolio
- 7.20.5 LabMal Recent Developments
- 7.21 GenomeScan
- 7.21.1 GenomeScan Company Information
- 7.21.2 GenomeScan Business Overview
- 7.21.3 GenomeScan Metagenomics Sequencing Services Revenue and Gross Margin (2021-2026)
- 7.21.4 GenomeScan Metagenomics Sequencing Services Product Portfolio
- 7.21.5 GenomeScan Recent Developments
8 North America
- 8.1 North America Metagenomics Sequencing Services Revenue (2021-2032)
- 8.2 North America Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 8.2.1 North America Metagenomics Sequencing Services Revenue by Type (2021-2026)
- 8.2.2 North America Metagenomics Sequencing Services Revenue by Type (2027-2032)
- 8.3 North America Metagenomics Sequencing Services Revenue Share by Type (2021-2032)
- 8.4 North America Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 8.4.1 North America Metagenomics Sequencing Services Revenue by Application (2021-2026)
- 8.4.2 North America Metagenomics Sequencing Services Revenue by Application (2027-2032)
- 8.5 North America Metagenomics Sequencing Services Revenue Share by Application (2021-2032)
- 8.6 North America Metagenomics Sequencing Services Revenue by Country
- 8.6.1 North America Metagenomics Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Metagenomics Sequencing Services Revenue by Country (2021-2026)
- 8.6.3 North America Metagenomics Sequencing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Metagenomics Sequencing Services Revenue (2021-2032)
- 9.2 Europe Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Metagenomics Sequencing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Metagenomics Sequencing Services Revenue by Type (2027-2032)
- 9.3 Europe Metagenomics Sequencing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Metagenomics Sequencing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Metagenomics Sequencing Services Revenue by Application (2027-2032)
- 9.5 Europe Metagenomics Sequencing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Metagenomics Sequencing Services Revenue by Country
- 9.6.1 Europe Metagenomics Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Metagenomics Sequencing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Metagenomics Sequencing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Metagenomics Sequencing Services Revenue (2021-2032)
- 10.2 China Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 10.2.1 China Metagenomics Sequencing Services Revenue by Type (2021-2026)
- 10.2.2 China Metagenomics Sequencing Services Revenue by Type (2027-2032)
- 10.3 China Metagenomics Sequencing Services Revenue Share by Type (2021-2032)
- 10.4 China Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 10.4.1 China Metagenomics Sequencing Services Revenue by Application (2021-2026)
- 10.4.2 China Metagenomics Sequencing Services Revenue by Application (2027-2032)
- 10.5 China Metagenomics Sequencing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Metagenomics Sequencing Services Revenue (2021-2032)
- 11.2 Asia Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Metagenomics Sequencing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Metagenomics Sequencing Services Revenue by Type (2027-2032)
- 11.3 Asia Metagenomics Sequencing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Metagenomics Sequencing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Metagenomics Sequencing Services Revenue by Application (2027-2032)
- 11.5 Asia Metagenomics Sequencing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Metagenomics Sequencing Services Revenue by Country
- 11.6.1 Asia Metagenomics Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Metagenomics Sequencing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Metagenomics Sequencing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Metagenomics Sequencing Services Revenue (2021-2032)
- 12.2 SAMEA Metagenomics Sequencing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Metagenomics Sequencing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Metagenomics Sequencing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Metagenomics Sequencing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Metagenomics Sequencing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Metagenomics Sequencing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Metagenomics Sequencing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Metagenomics Sequencing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Metagenomics Sequencing Services Revenue by Country
- 12.6.1 SAMEA Metagenomics Sequencing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Metagenomics Sequencing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Metagenomics Sequencing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst